X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

RENAL FAILURE

期刊標題檢索 RENAL FAILURE 最新評論: May I ask when can we expect the results to be available for review? (2024-11-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[RENAL FAILURE]您好,您是該頁面的第 56162 位訪客。

期刊簡介
期刊名稱RENAL FAILURE RENAL FAILURE
LetPub Score
5.3
50 ratings
Rate

Reputation
5.9

Influence
4.0

Speed
8.8

期刊簡稱RENAL FAILURE
ISSN0886-022X
E-ISSN1525-6049
h-index49
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.900.7270.916
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Critical Care and Intensive Care Medicine
Q238 / 110
Category: Medicine
Subcategory: Nephrology
Q232 / 81

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Renal Failure primarily concentrates on acute renal injury and its consequence, but also addresses advances in the fields of chronic renal failure, hypertension, and renal transplantation. Bringing together both clinical and experimental aspects of renal failure, this publication presents timely, practical information on pathology and pathophysiology of acute renal failure; nephrotoxicity of drugs and other substances; prevention, treatment, and therapy of renal failure; renal failure in association with transplantation, hypertension, and diabetes mellitus.
官方網站https://www.tandfonline.com/loi/irnf20
在線稿件提交https://rp.tandfonline.com/submission/login
開放訪問Yes
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1987
每年文章數315每年文章數趨勢
黃金OA百分比97.78%
OA Related Info
APC: Yes( GBP2100; )
APC waiver:Check Notes
Other charges: No
Keywords: kidney failure、renal injury、kidney transplantation、hypertension、diabetes mellitus、renal pathology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
UROLOGY & NEPHROLOGYSCIEQ129/126
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0886-022X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【RENAL FAILURE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews NephrologyH-index: 88

    CiteScore: 39.00
    EUROPEAN UROLOGYH-index: 187

    CiteScore: 43.00
    KIDNEY INTERNATIONALH-index: 250

    CiteScore: 23.30
    Nature Reviews UrologyH-index: 65

    CiteScore: 12.50
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYH-index: 253

    CiteScore: 22.40
    AMERICAN JOURNAL OF KIDNEY DISEASESH-index: 196

    CiteScore: 20.40
    Clinical Journal of the American Society of NephrologyH-index: 128

    CiteScore: 12.20
    JOURNAL OF UROLOGYH-index: 236

    CiteScore: 11.50
    PROSTATE CANCER AND PROSTATIC DISEASESH-index: 56

    CiteScore: 10.00
    NEPHROLOGY DIALYSIS TRANSPLANTATIONH-index: 155

    CiteScore: 10.10
    學科內最受檢索的期刊 頁面查看次數
    KIDNEY INTERNATIONAL58876
    JOURNAL OF UROLOGY51884
    BJU INTERNATIONAL49354
    EUROPEAN UROLOGY44655
    INTERNATIONAL UROLOGY AND NEPHROLOGY43152
    UROLOGY42128
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY40565
    ASIAN JOURNAL OF ANDROLOGY39347
    PROSTATE38708
    NEPHROLOGY DIALYSIS TRANSPLANTATION38553
  •  

    RENAL FAILURE RENAL FAILURE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [RENAL FAILURE] 的評論撰寫評論
作者: 小刘爱科研


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-17 19:30:19 評論於
May I ask when can we expect the results to be available for review?
(0) 讚! | 小刘爱科研

作者: 努力啊大代玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 16:48:11 評論於
How long does it take for review? Is it normal that it has been a month and still "with editor"?
(0) 讚! | 努力啊大代玉

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-12 21:59:28 評論於
With your sharing, I feel more confident for my next submission.
(0) 讚! | Adelaide Lawson

作者: cuihhua


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-10 13:19:27 評論於
Isn't the review period supposed to be 3 months? How did it become 6 months?
(0) 讚! | cuihhua

作者: liuxh777


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-10 10:38:48 評論於
Three months after submission, the review results were received. Due to significant differences in opinions from the first two reviewers, the editor invited a third reviewer. Fortunately, the third reviewer provided a very positive feedback, and after incorporating the suggestions from the editor, a major revision was required. After six weeks of revision, the manuscript was resubmitted for the second round of review. The second review process took approximately two weeks before further revisions were requested. After resubmitting, the manuscript entered the third round of review and was accepted one week later.

The entire process from submission to acceptance took six months. The editor and reviewers demonstrated professionalism and responsibility, and their responses to emails were timely. The review process was well-organized. Highly recommended.
(0) 讚! | liuxh777

作者: 东风谷殿原


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-07 16:40:36 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The review speed is relatively fast, and the manuscript was returned for major revision in less than 3 months after submission. Because the opinions of the first two reviewers were quite divergent, a third reviewer was sought. Fortunately, the third reviewer's comments were more positive, and after the chief editor also provided corresponding modification suggestions, a major revision was granted. Due to the large workload, a delay notice was sent to the editor two weeks after the revisions. The revised manuscript was submitted one and a half months later for a second review. After 2 weeks, revision suggestions were returned, and the manuscript was submitted again after further modifications. Acceptance was received 10 days after the third review. The process from submission to acceptance took 6 months. The comments from the editor and reviewers were very professional, and the process was very standardized. Looking forward to Renal Failure getting better and better.
(0) 讚! | 东风谷殿原

作者: 华山晴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-05 23:41:39 評論於
Submit your manuscript according to the author guidelines, but I forgot the specific details.
(0) 讚! | 华山晴文

作者: 华山晴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-05 08:37:21 評論於
Is everything okay? Did you receive it?
(0) 讚! | 华山晴文

作者: 暴风风芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-26 11:16:04 評論於
Review speed: 6.0 | Submission hit rate: 75.0
Emphasized research direction: Nephrology
Experience sharing: Come back to the forum after publication. After three months since the first submission, many reminders were sent before finally sending it out for external review. The external review came back in a week, with feedback from four reviewers: 1 rejection, 1 major revision, 2 minor revisions, and finally a chance for revision. After revising, feedback on minor revisions from the original reviewer came back after 3 weeks, followed by quick proofreading and publication. In summary, the journal's requirements were not very high, and the formatting was not strictly followed when submitting. Changes were only required during the revision process, and the editor did not provide much feedback throughout. Once the reviewers agreed to publication, the paper was accepted. It feels like the editor is more inclined to accept submissions. It's just unclear why it took so long for the external review to be conducted. Those with sufficient time can give it a try.
(0) 讚! | 暴风风芹

作者: 中论文


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-22 08:40:56 評論於
The review process was slightly long, taking 5 months from submission to acceptance. There were four reviewers and a few issues, with a month given for revisions. After major revisions and a second review, the paper was accepted. The publication fee is $2990, which is a bit expensive.
(0) 讚! | 中论文

作者: 西行寺灵卉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 22:44:52 評論於
Hello, is it normal for a decision pending for 3 days after being revised?
(0) 讚! | 西行寺灵卉

作者: 佳杰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 17:16:18 評論於
When submitting a manuscript, should Figures be uploaded separately? If Figures are included in the Manuscript, the file size will exceed 128M. If Figures are uploaded separately, what category should be selected (Supplementary materials)?
(0) 讚! | 佳杰三岁啦

作者: 佳杰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 15:48:47 評論於
When submitting a manuscript, should Figures be uploaded separately? If Figures are included in the Manuscript, the size will exceed 128M. If Figures are uploaded separately, what category should be selected (Supplementary materials?)
(0) 讚! | 佳杰三岁啦

作者: 佳杰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 15:36:50 評論於
When submitting a manuscript, should Figures be uploaded separately? If Figures are included in the Manuscript, the file size will exceed 128M. If Figures are uploaded separately, what category should be selected (Supplementary materials)?
(0) 讚! | 佳杰三岁啦

作者: 佳杰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 11:31:29 評論於
When submitting a manuscript, should Figures be uploaded separately? If Figures are included in the Manuscript, the file size will exceed 128M. If Figures are uploaded separately, what category should be selected (Supplementary materials)?
(0) 讚! | 佳杰三岁啦

作者: 佳杰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 11:04:58 評論於
When submitting a manuscript, should Figures be uploaded separately? If Figures are included in the Manuscript, the file size will exceed 128M. If Figures are uploaded separately, what category should be selected (Supplementary materials)?
(0) 讚! | 佳杰三岁啦

作者: 半月廷谦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-19 17:16:36 評論於
Often like this, this webpage can only wait.
(0) 讚! | 半月廷谦

作者: 彝断李


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-19 09:50:26 評論於
Could you please tell me how much the layout fee is?
(0) 讚! | 彝断李

作者: 华山晴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-12 10:41:44 評論於
You can see it by clicking on submit again.
(0) 讚! | 华山晴文

作者: 法慧越泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-09 16:33:51 評論於
Where can I see the progress of my submission in this magazine? I submitted it but I can't see my article.
(0) 讚! | 法慧越泽

作者: 法慧越泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-09 11:28:58 評論於
Where can I see the progress of my submission in this magazine? I submitted it but can't see my article.
(0) 讚! | 法慧越泽

作者: 法慧越泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-09 09:03:44 評論於
Excuse me, where can I see the progress of my submissions in this magazine? I submitted my article but I can't see it.
(0) 讚! | 法慧越泽

作者: 华山晴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 23:03:35 評論於
Review speed: 6.0 | Submission success rate: 50.0
Research direction emphasis: Nephrology
Experience sharing: Helped senior fellow to submit
Experience sharing: Submitted on 12th May 2023; Major revision on 16th July 2023; Submitted after major revision on 9th August 2023; Submitted again after further revision on 11th August 2023; Accepted on the same day of decision on 31st August 2023; Took a total of 3 and a half months, encountered friendly reviewers and editors, grateful
(1) 讚! | 华山晴文

作者: 锦欣君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-14 15:09:16 評論於
I also made the decision directly. It has only been two days, so I wonder if it has been submitted for approval
(0) 讚! | 锦欣君

作者: 锦欣君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-12 13:42:09 評論於
I want to ask if it basically means a rejection when a manuscript goes from "With Editor" directly to "Decision Pending" without going through the "Out for Review" step
(0) 讚! | 锦欣君

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [RENAL FAILURE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*